- Home
- IGMS vs CGTL Comparison
IGMS vs CGTL Comparison
Compare IGMS & CGTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGMS
- CGTL
- Stock Information
- Founded
- IGMS 1993
- CGTL 2016
- Country
- IGMS United States
- CGTL Hong Kong
- Employees
- IGMS N/A
- CGTL N/A
- Industry
- IGMS Biotechnology: Pharmaceutical Preparations
- CGTL
- Sector
- IGMS Health Care
- CGTL
- Exchange
- IGMS Nasdaq
- CGTL NYSE
- Market Cap
- IGMS 82.1M
- CGTL 70.3M
- IPO Year
- IGMS 2019
- CGTL 2024
- Fundamental
- Price
- IGMS $1.22
- CGTL $5.62
- Analyst Decision
- IGMS Hold
- CGTL
- Analyst Count
- IGMS 8
- CGTL 0
- Target Price
- IGMS $6.14
- CGTL N/A
- AVG Volume (30 Days)
- IGMS 167.6K
- CGTL 628.1K
- Earning Date
- IGMS 05-07-2025
- CGTL 05-15-2025
- Dividend Yield
- IGMS N/A
- CGTL N/A
- EPS Growth
- IGMS N/A
- CGTL 35.72
- EPS
- IGMS N/A
- CGTL 0.21
- Revenue
- IGMS $2,679,000.00
- CGTL $35,611,761.00
- Revenue This Year
- IGMS $121.76
- CGTL N/A
- Revenue Next Year
- IGMS $46.83
- CGTL N/A
- P/E Ratio
- IGMS N/A
- CGTL $26.25
- Revenue Growth
- IGMS 25.77
- CGTL N/A
- 52 Week Low
- IGMS $0.92
- CGTL $2.80
- 52 Week High
- IGMS $22.50
- CGTL $10.59
- Technical
- Relative Strength Index (RSI)
- IGMS 47.65
- CGTL N/A
- Support Level
- IGMS $1.16
- CGTL N/A
- Resistance Level
- IGMS $1.31
- CGTL N/A
- Average True Range (ATR)
- IGMS 0.12
- CGTL 0.00
- MACD
- IGMS 0.03
- CGTL 0.00
- Stochastic Oscillator
- IGMS 76.92
- CGTL 0.00
About IGMS IGM Biosciences Inc.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.
About CGTL CREATIVE GLOBAL TECHNOLOGY HOLDINGS LIMITED
Creative Global Technology Holdings Ltd conducts its business through its subsidiary, which is a Hong Kong-based company sourcing and reselling recycled consumer electronic devices, currently mostly smartphones, tablets, and laptops.